Switzerland

A block trade and the conversion of a loan into shares are providing the capital to buy a rival aerospace components maker

The majority shareholders of the Swiss pharma chemicals firm sold Sfr171 of shares at the end of the post-IPO lockup

Swiss medical equipment firm is expected to list this week

Swiss pharma firm's stock rose after it announced dilutive block trade

Ebusco and Skan cover books within hours of setting price ranges

Commodities company’s sustainability-linked loan gets solid demand, allowing for a big size increase

Banks have been mandated on several deals due to come in the next few months

Kernkraftwerk Gösgen-Däniken split open a quiet Swiss franc market on Monday as it looked to slip in ahead of the post-summer rush, landing its eight year bond 3bp through fair value.

UBS was hot on the heels of Credit Suisse with a new issuance in the dollar market this week, as banks spy an opportunity to get funding done in early August.

Idorsia, the Swiss biotech company, has turned to the convertible bond market to finance looming product launches and the development of its late-stage drug pipeline.

Reinout Böttcher is leaving UBS, where he was head of global banking for Switzerland, for a vice-chair role at JP Morgan in Zurich.

UBS opened the European bank earnings season on Tuesday with a strong set of results from its M&A and capital markets businesses, which CEO Ralph Hamers seized as an opportunity to play up the importance of talented bankers over the generous application of balance sheet.